| pubmed-article:12788569 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12788569 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12788569 | lifeskim:mentions | umls-concept:C1277187 | lld:lifeskim |
| pubmed-article:12788569 | lifeskim:mentions | umls-concept:C0014025 | lld:lifeskim |
| pubmed-article:12788569 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
| pubmed-article:12788569 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:12788569 | lifeskim:mentions | umls-concept:C0023671 | lld:lifeskim |
| pubmed-article:12788569 | lifeskim:mentions | umls-concept:C0016441 | lld:lifeskim |
| pubmed-article:12788569 | pubmed:issue | 9372 | lld:pubmed |
| pubmed-article:12788569 | pubmed:dateCreated | 2003-6-5 | lld:pubmed |
| pubmed-article:12788569 | pubmed:abstractText | In the studies of left ventricular dysfunction (SOLVD), enalapril reduced mortality in patients with symptomatic but not asymptomatic left ventricular systolic dysfunction during the trial. We did a 12-year follow-up of SOLVD to establish if the mortality reduction with enalapril among patients with heart failure was sustained, and whether a subsequent reduction in mortality would emerge among those with asymptomatic ventricular dysfunction. | lld:pubmed |
| pubmed-article:12788569 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12788569 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12788569 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:12788569 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12788569 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12788569 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12788569 | pubmed:month | May | lld:pubmed |
| pubmed-article:12788569 | pubmed:issn | 0140-6736 | lld:pubmed |
| pubmed-article:12788569 | pubmed:author | pubmed-author:YusufSalimS | lld:pubmed |
| pubmed-article:12788569 | pubmed:author | pubmed-author:BangdiwalaShr... | lld:pubmed |
| pubmed-article:12788569 | pubmed:author | pubmed-author:JongPhilipP | lld:pubmed |
| pubmed-article:12788569 | pubmed:author | pubmed-author:AhnSylvie ASA | lld:pubmed |
| pubmed-article:12788569 | pubmed:author | pubmed-author:RousseauMiche... | lld:pubmed |
| pubmed-article:12788569 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12788569 | pubmed:day | 31 | lld:pubmed |
| pubmed-article:12788569 | pubmed:volume | 361 | lld:pubmed |
| pubmed-article:12788569 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12788569 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12788569 | pubmed:pagination | 1843-8 | lld:pubmed |
| pubmed-article:12788569 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:12788569 | pubmed:meshHeading | pubmed-meshheading:12788569... | lld:pubmed |
| pubmed-article:12788569 | pubmed:meshHeading | pubmed-meshheading:12788569... | lld:pubmed |
| pubmed-article:12788569 | pubmed:meshHeading | pubmed-meshheading:12788569... | lld:pubmed |
| pubmed-article:12788569 | pubmed:meshHeading | pubmed-meshheading:12788569... | lld:pubmed |
| pubmed-article:12788569 | pubmed:meshHeading | pubmed-meshheading:12788569... | lld:pubmed |
| pubmed-article:12788569 | pubmed:meshHeading | pubmed-meshheading:12788569... | lld:pubmed |
| pubmed-article:12788569 | pubmed:meshHeading | pubmed-meshheading:12788569... | lld:pubmed |
| pubmed-article:12788569 | pubmed:meshHeading | pubmed-meshheading:12788569... | lld:pubmed |
| pubmed-article:12788569 | pubmed:meshHeading | pubmed-meshheading:12788569... | lld:pubmed |
| pubmed-article:12788569 | pubmed:meshHeading | pubmed-meshheading:12788569... | lld:pubmed |
| pubmed-article:12788569 | pubmed:meshHeading | pubmed-meshheading:12788569... | lld:pubmed |
| pubmed-article:12788569 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12788569 | pubmed:articleTitle | Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study. | lld:pubmed |
| pubmed-article:12788569 | pubmed:affiliation | Population Health Research Institute, and Division of Cardiology, Hamilton General Hospital, McMaster University, Hamilton, ON, Canada. | lld:pubmed |
| pubmed-article:12788569 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:12788569 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:12788569 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| pubmed-article:12788569 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12788569 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12788569 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12788569 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12788569 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12788569 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12788569 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12788569 | lld:pubmed |
